Clinical Trials Logo

Melanoma Stage III clinical trials

View clinical trials related to Melanoma Stage III.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04455503 Terminated - Melanoma Stage IV Clinical Trials

Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1

Start date: July 13, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase 1/2, open label, multi-centre study to assess the safety, tolerability, PD, and efficacy of adjuvant immunotherapy EVX-02 vaccine and anti-PD-1 (Nivolumab) in patients who have had a complete resection of a Stage IIIB/IIIC/IIID or Stage IV melanoma who are at high risk of recurrence.

NCT ID: NCT04410445 Terminated - Melanoma Clinical Trials

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

PIVOT-12
Start date: July 27, 2020
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to compare the efficacy of bempegaldesleukin plus nivolumab versus nivolumab in patients with completely resected Stage IIIA/B/C/D, or Stage IV cutaneous melanoma who are at high risk for recurrence.